131 related articles for article (PubMed ID: 32825359)
41. Effects of organic anion transporting polypeptide 1B1 haplotype on pharmacokinetics of pravastatin, valsartan, and temocapril.
Maeda K; Ieiri I; Yasuda K; Fujino A; Fujiwara H; Otsubo K; Hirano M; Watanabe T; Kitamura Y; Kusuhara H; Sugiyama Y
Clin Pharmacol Ther; 2006 May; 79(5):427-39. PubMed ID: 16678545
[TBL] [Abstract][Full Text] [Related]
42. Risk of hand-foot skin reaction with sorafenib: a systematic review and meta-analysis.
Chu D; Lacouture ME; Fillos T; Wu S
Acta Oncol; 2008; 47(2):176-86. PubMed ID: 18210295
[TBL] [Abstract][Full Text] [Related]
43. Influence of OATP1B1 Function on the Disposition of Sorafenib-β-D-Glucuronide.
Bins S; van Doorn L; Phelps MA; Gibson AA; Hu S; Li L; Vasilyeva A; Du G; Hamberg P; Eskens F; de Bruijn P; Sparreboom A; Mathijssen R; Baker SD
Clin Transl Sci; 2017 Jul; 10(4):271-279. PubMed ID: 28371445
[TBL] [Abstract][Full Text] [Related]
44. Aspirin and probenecid inhibit organic anion transporter 3-mediated renal uptake of cilostazol and probenecid induces metabolism of cilostazol in the rat.
Wang C; Wang C; Liu Q; Meng Q; Cang J; Sun H; Peng J; Ma X; Huo X; Liu K
Drug Metab Dispos; 2014 Jun; 42(6):996-1007. PubMed ID: 24692216
[TBL] [Abstract][Full Text] [Related]
45. Phase II study to investigate the efficacy, safety, and pharmacokinetics of sorafenib in Japanese patients with advanced renal cell carcinoma.
Akaza H; Tsukamoto T; Murai M; Nakajima K; Naito S
Jpn J Clin Oncol; 2007 Oct; 37(10):755-62. PubMed ID: 17951335
[TBL] [Abstract][Full Text] [Related]
46. Influence of Calcineurin Inhibitor and Sex on Mycophenolic Acid Pharmacokinetics and Adverse Effects Post-Renal Transplant.
Meaney CJ; Sudchada P; Consiglio JD; Wilding GE; Cooper LM; Venuto RC; Tornatore KM
J Clin Pharmacol; 2019 Oct; 59(10):1351-1365. PubMed ID: 31062373
[TBL] [Abstract][Full Text] [Related]
47. Pharmacokinetics of enrofloxacin and its metabolite ciprofloxacin in goats given enrofloxacin alone and in combination with probenecid.
Rao GS; Ramesh S; Ahmad AH; Tripathi HC; Sharma LD; Malik JK
Vet J; 2002 Jan; 163(1):85-93. PubMed ID: 11749141
[TBL] [Abstract][Full Text] [Related]
48. Pharmacokinetic interactions of cefprozil with food, propantheline, metoclopramide, and probenecid in healthy volunteers.
Shukla UA; Pittman KA; Barbhaiya RH
J Clin Pharmacol; 1992 Aug; 32(8):725-31. PubMed ID: 1487562
[TBL] [Abstract][Full Text] [Related]
49. Effects of Ascorbyl-2-phosphate Magnesium on Human Keratinocyte Toxicity and Pathological Changes by Sorafenib.
Yamamoto K; Shichiri H; Ishida T; Kaku K; Nishioka T; Kume M; Makimoto H; Nakagawa T; Hirano T; Bito T; Nishigori C; Yano I; Hirai M
Biol Pharm Bull; 2017; 40(9):1530-1536. PubMed ID: 28867735
[TBL] [Abstract][Full Text] [Related]
50. Bioequivalence of Linagliptin 5 mg once daily and 2.5 mg twice daily: pharmacokinetics and pharmacodynamics in an open-label crossover trial.
Friedrich C; Jungnik A; Retlich S; Ring A; Meinicke T
Drug Res (Stuttg); 2014 May; 64(5):269-75. PubMed ID: 24154935
[TBL] [Abstract][Full Text] [Related]
51. Renal responses and pharmacokinetics of piretanide in humans: effect of route of administration, state of hydration and probenecid pretreatment.
Noormohamed FH; McNabb WR; Dixey JJ; Lant AF
J Pharmacol Exp Ther; 1990 Sep; 254(3):992-9. PubMed ID: 2395126
[TBL] [Abstract][Full Text] [Related]
52. Sorafenib-associated hand-foot skin reaction: practical advice on diagnosis, mechanism, prevention, and management.
Ai L; Xu Z; Yang B; He Q; Luo P
Expert Rev Clin Pharmacol; 2019 Dec; 12(12):1121-1127. PubMed ID: 31679411
[No Abstract] [Full Text] [Related]
53. Effects of rifampin, cyclosporine A, and probenecid on the pharmacokinetic profile of canagliflozin, a sodium glucose co-transporter 2 inhibitor, in healthy participants.
Devineni D; Vaccaro N; Murphy J; Curtin C; Mamidi RN; Weiner S; Wang SS; Ariyawansa J; Stieltjes H; Wajs E; Di Prospero NA; Rothenberg P
Int J Clin Pharmacol Ther; 2015 Feb; 53(2):115-28. PubMed ID: 25407255
[TBL] [Abstract][Full Text] [Related]
54. Comparative effects of rifampin and/or probenecid on the pharmacokinetics of temazepam and nitrazepam.
Brockmeyer NH; Mertins L; Klimek K; Goos M; Ohnhaus EE
Int J Clin Pharmacol Ther Toxicol; 1990 Sep; 28(9):387-93. PubMed ID: 2228325
[TBL] [Abstract][Full Text] [Related]
55. Pharmacokinetics of oral ganciclovir alone and in combination with zidovudine, didanosine, and probenecid in HIV-infected subjects.
Cimoch PJ; Lavelle J; Pollard R; Griffy KG; Wong R; Tarnowski TL; Casserella S; Jung D
J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Mar; 17(3):227-34. PubMed ID: 9495222
[TBL] [Abstract][Full Text] [Related]
56. Randomized controlled trial of the prophylactic effect of urea-based cream on sorafenib-associated hand-foot skin reactions in patients with advanced hepatocellular carcinoma.
Ren Z; Zhu K; Kang H; Lu M; Qu Z; Lu L; Song T; Zhou W; Wang H; Yang W; Wang X; Yang Y; Shi L; Bai Y; Guo X; Ye SL
J Clin Oncol; 2015 Mar; 33(8):894-900. PubMed ID: 25667293
[TBL] [Abstract][Full Text] [Related]
57. The effect of herbal medicine baicalin on pharmacokinetics of rosuvastatin, substrate of organic anion-transporting polypeptide 1B1.
Fan L; Zhang W; Guo D; Tan ZR; Xu P; Li Q; Liu YZ; Zhang L; He TY; Hu DL; Wang D; Zhou HH
Clin Pharmacol Ther; 2008 Mar; 83(3):471-6. PubMed ID: 17851565
[TBL] [Abstract][Full Text] [Related]
58. The effect of probenecid on the pharmacokinetics of zalcitabine in HIV-positive patients.
Massarella JW; Nazareno LA; Passe S; Min B
Pharm Res; 1996 Mar; 13(3):449-52. PubMed ID: 8692740
[TBL] [Abstract][Full Text] [Related]
59. Multiple human isoforms of drug transporters contribute to the hepatic and renal transport of olmesartan, a selective antagonist of the angiotensin II AT1-receptor.
Yamada A; Maeda K; Kamiyama E; Sugiyama D; Kondo T; Shiroyanagi Y; Nakazawa H; Okano T; Adachi M; Schuetz JD; Adachi Y; Hu Z; Kusuhara H; Sugiyama Y
Drug Metab Dispos; 2007 Dec; 35(12):2166-76. PubMed ID: 17823233
[TBL] [Abstract][Full Text] [Related]
60. Investigation of bioequivalence of a new fixed-dose combination of acarbose and metformin with the corresponding loose combination as well as the drug-drug interaction potential between both drugs in healthy adult male subjects.
Kim S; Jang IJ; Shin D; Shin DS; Yoon S; Lim KS; Yu KS; Li J; Zhang H; Liu Y; Brendel E; Blode H; Wang Y
J Clin Pharm Ther; 2014 Aug; 39(4):424-31. PubMed ID: 24806030
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
